We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mutation Repairs Retrovirus Damage in Mouse Model

By Biotechdaily staff writers
Posted on 09 Oct 2003
A recent study has identified a gene in mice that can restore the function of other genes that have been damaged by retrovirus infection by stimulating the synthesis of mRNA for the normal protein coded by the gene.

Investigators at the University of California, San Diego (USA), working with a mice model showed that animals with a mutation in the mRNA nuclear export factor gene (Nxf1) were able to alleviate retrovirus damage by increasing the amount of normal protein produced by the damaged gene. More...


The investigators studied a line of mice known as "vibrator” that have severe tremors, progressive degeneration of the brain stem and spinal cord, and premature death. Vibrator mice that carried the mvb1 gene (Modifier-of-vibrator-1, which reduces the damaging characteristics of the vibrator neurologic gene mutation caused by insertion of the mouse IAP retrovirus) showed reduced tremor severity and survived to adulthood. Mvb1 raised the amount of normal RNA made from the mutant vibrator gene.

Mvb1 was also found to partially alleviate the Eya1 mutation that is a mouse model of human branchio-otorenal syndrome, which is also caused by an IAP retrovirus. The investigators further reported in the September 28, 2003, issue of Nature Genetics that positional complementation showed that Mvb1 is part of the mRNA nuclear export factor Nxf1.

"The properties of this gene could be used to engineer a system for controlling some mutations caused by retroviruses,” said senior author Dr. Bruce Hamilton, assistant professor of medicine at the University of California, San Diego. "This could be particularly useful for creating mouse models of human disorders where loss of gene expression is a target of therapeutic efforts, but the dose-responsiveness required for functional recovery is unknown, such as in Fragile X syndrome and certain cancers.”




Related Links:
University of California, San Diego

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.